22nd Century Group Inc (NASDAQ:XXII)
| 0.8801 BATS BZX Real-Time Price As of 1:56pm ET |  +0.0442 / +5.29%Today’s Change | 0.81 Today|||52-Week Range 2.70 | -4.39% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $192.0M |
Company Description
22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco and Hemp/Cannabis segments. The Tobacco segment manufactures branded filtered cigars and cigarettes. The Hemp/Cannabis segment focuses on the bulk ingredient distillate or isolate. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.
Contact Information
22nd Century Group, Inc. 500 Seneca Street Buffalo New York 14204 |
Employees
Shareholders
| Other institutional | 7.38% |
| Mutual fund holders | 11.93% |
| Individual stakeholders | 11.91% |
Top Executives
| James A Mish | President, Chief Executive Officer & Director |
| John J. Miller | Chief Operating Officer & President-Tobacco |
| Robert Hugh Kinsman | Chief Financial Officer |
| Juan Sanchez Tamburrino | Vice President-Research & Development |
| Calvin Treat | Chief Scientific Officer |
